Altimmune, Inc.
ALT
Revenue
5.00k
0.000.00%
3 Months ChangeAssets
173.35M
▼-15.01M▼-7.97%
3 Months ChangeLiabilities
20.82M
▲5.39M▲34.98%
3 Months ChangeFree Cash Flow
-19.46M
▼-5.92M▼-43.76%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-26
Form 8-K
ID: 0001326190-24-000042
2024-08-15
Form 8-K
ID: 0001326190-24-000036
2024-08-08
Form 10-Q
ID: 0001326190-24-000030
2024-08-08
Form 8-K
ID: 0001326190-24-000027
2024-06-26
Form 8-K
ID: 0001326190-24-000022
2024-05-09
Form 10-Q
ID: 0001326190-24-000019
2024-05-09
Form 8-K
ID: 0001326190-24-000016
2024-03-27
Form 8-K
ID: 0001326190-24-000006
2023-11-30
Form 8-K
ID: 0001326190-23-000050
2023-11-07
Form 10-Q
ID: 0001326190-23-000047